Tsang Clarisse A, Langer Adam J, Navin Thomas R, Armstrong Lori R
Division of TB Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.
MMWR Morb Mortal Wkly Rep. 2017 Mar 24;66(11):295-298. doi: 10.15585/mmwr.mm6611a3.
The majority of tuberculosis (TB) cases in the United States are attributable to reactivation of latent TB infection (LTBI) (1). LTBI refers to the condition when a person is infected with Mycobacterium tuberculosis without signs and symptoms, or radiographic or bacteriologic evidence of TB disease. CDC and the U.S. Preventive Services Task Force (USPSTF) recommend screening populations at increased risk for LTBI, including persons who have lived in congregate settings at high risk and persons who were born in, or are former residents of countries with TB incidence ≥20 cases per 100,000 population (2-4). In 2015, foreign-born persons constituted 66.2% of U.S. TB cases (5). During the past 30 years, screening of persons from countries with high TB rates has focused on overseas screening for immigrants and refugees, and domestic screening for persons who have newly arrived in the United States (6,7). However, since 2007, an increasing number and proportion of foreign-born patients receiving a diagnosis of TB first arrived in the United States ≥10 years before the development and diagnosis of TB disease. To better understand how this group of patients differs from persons who developed TB disease and received a diagnosis <10 years after U.S. arrival, CDC analyzed data for all reported TB cases in the United States since 1993 in the National TB Surveillance System (NTSS). After adjusting for age and other characteristics, foreign-born persons who arrived in the United States ≥10 years before diagnosis were more likely to be residents of a long-term care facility or to have immunocompromising conditions other than human immunodeficiency virus (HIV) infection. These findings support using the existing CDC and USPSTF recommendations for TB screening of persons born in countries with high TB rates regardless of time since arrival in the United States (2,3).
美国大多数结核病(TB)病例是由潜伏性结核感染(LTBI)的重新激活所致(1)。LTBI是指一个人感染结核分枝杆菌但没有结核病的体征和症状,也没有结核病的影像学或细菌学证据的情况。美国疾病控制与预防中心(CDC)和美国预防服务工作组(USPSTF)建议对LTBI风险增加的人群进行筛查,包括居住在高风险群居环境中的人,以及出生在结核病发病率≥每10万人口20例的国家或曾是这些国家居民的人(2 - 4)。2015年,外国出生的人占美国结核病病例的66.2%(5)。在过去30年里,对来自结核病高发病率国家的人的筛查主要集中在对移民和难民的海外筛查,以及对新抵达美国的人的国内筛查(6,7)。然而,自2007年以来,越来越多首次被诊断为结核病的外国出生患者在结核病发病和诊断前≥10年就已抵达美国。为了更好地了解这组患者与在美国抵达后<10年发病并被诊断为结核病的患者有何不同,CDC分析了1993年以来美国国家结核病监测系统(NTSS)中所有报告的结核病病例数据。在对年龄和其他特征进行调整后,在诊断前≥10年抵达美国的外国出生者更有可能是长期护理机构的居民,或患有除人类免疫缺陷病毒(HIV)感染以外的免疫功能低下疾病。这些发现支持使用CDC和USPSTF现有的针对出生在结核病高发病率国家人群的结核病筛查建议,而不考虑其抵达美国后的时间(2,3)。